Nomura Holdings’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-827
| Closed | -$228K | – | 2160 |
|
|
2025
Q4 | $228K | Sell |
827
-5,853
| -88% | -$1.6M | ﹤0.01% | 1743 |
|
|
2025
Q3 | $1.75M | Buy |
6,680
+1,434
| +27% | +$349K | ﹤0.01% | 1186 |
|
|
2025
Q2 | $1.15M | Buy |
5,246
+212
| +4% | +$45.3K | ﹤0.01% | 967 |
|
|
2025
Q1 | $1.13M | Buy |
5,034
+2,652
| +111% | +$731K | ﹤0.01% | 1239 |
|
|
2024
Q4 | $780K | Sell |
2,382
-1,556
| -40% | -$490K | ﹤0.01% | 1595 |
|
|
2024
Q3 | $1.18M | Sell |
3,938
-2,305
| -37% | -$706K | ﹤0.01% | 1099 |
|
|
2024
Q2 | $2.06M | Buy |
6,243
+3,311
| +113% | +$1.17M | ﹤0.01% | 934 |
|
|
2024
Q1 | $1.16M | Buy |
2,932
+798
| +37% | +$295K | ﹤0.01% | 1057 |
|
|
2023
Q4 | $751K | Buy |
2,134
+445
| +26% | +$157K | ﹤0.01% | 1257 |
|
|
2023
Q3 | $634K | Sell |
1,689
-1,525
| -47% | -$590K | ﹤0.01% | 1083 |
|
|
2023
Q2 | $1.23M | Sell |
3,214
-1,315
| -29% | -$470K | ﹤0.01% | 857 |
|
|
2023
Q1 | $1.57M | Buy |
4,529
+2,868
| +173% | +$838K | 0.01% | 881 |
|
|
2022
Q4 | $391K | Sell |
1,661
-1,950
| -54% | -$462K | ﹤0.01% | 1017 |
|
|
2022
Q3 | $891K | Buy |
3,611
+104
| +3% | +$31.7K | ﹤0.01% | 986 |
|
|
2022
Q2 | $1.07M | Buy |
3,507
+1,021
| +41% | +$332K | ﹤0.01% | 941 |
|
|
2022
Q1 | $1.03M | Sell |
2,486
-1,621
| -39% | -$635K | ﹤0.01% | 1105 |
|
|
2021
Q4 | $1.93M | Sell |
4,107
-1,164
| -22% | -$501K | ﹤0.01% | 1011 |
|
|
2021
Q3 | $2.21M | Buy |
5,271
+241
| +5% | +$102K | 0.01% | 886 |
|
|
2021
Q2 | $1.81M | Buy |
5,030
+481
| +11% | +$159K | ﹤0.01% | 900 |
|
|
2021
Q1 | $1.28M | Buy |
4,549
+1,416
| +45% | +$405K | ﹤0.01% | 1008 |
|
|
2020
Q4 | $887K | Buy |
3,133
+1,301
| +71% | +$365K | ﹤0.01% | 1072 |
|
|
2020
Q3 | $504K | Sell |
1,832
-2,490
| -58% | -$659K | ﹤0.01% | 1003 |
|
|
2020
Q2 | $981K | Buy |
+4,322
| New | +$849K | ﹤0.01% | 719 |
|
|
2019
Q3 | – | Sell |
-5,000
| Closed | -$624K | – | 1425 |
|
|
2019
Q2 | $624K | Buy |
5,000
+1,500
| +43% | +$177K | ﹤0.01% | 914 |
|
|
2019
Q1 | $391K | Buy |
+3,500
| New | +$364K | ﹤0.01% | 953 |
|
|
2018
Q1 | – | Sell |
-4,124
| Closed | -$407K | – | 1709 |
|
|
2017
Q4 | $407K | Sell |
4,124
-981
| -19% | -$96.2K | ﹤0.01% | 1357 |
|
|
2017
Q3 | $491K | Buy |
5,105
+2,982
| +140% | +$270K | ﹤0.01% | 1260 |
|
|
2017
Q2 | $201K | Buy |
+2,123
| New | +$195K | ﹤0.01% | 1400 |
|
|
2015
Q2 | – | Sell |
-4,660
| Closed | -$273K | – | 2064 |
|
|
2015
Q1 | $273K | Sell |
4,660
-1,120
| -19% | -$59.7K | ﹤0.01% | 1381 |
|
|
2014
Q4 | $303K | Buy |
+5,780
| New | +$289K | ﹤0.01% | 1899 |
|
|
2014
Q3 | – | Sell |
-7,649
| Closed | -$322K | – | 3083 |
|
|
2014
Q2 | $322K | Sell |
7,649
-18,612
| -71% | -$797K | ﹤0.01% | 2077 |
|
|
2014
Q1 | $1.16M | Buy |
+26,261
| New | +$1.24M | ﹤0.01% | 1415 |
|
Other funds holding WST
VCM
VPM
GIM
Nomura Holdings's WST Position: Q1 2026 in Review
Nomura Holdings sold out of West Pharmaceutical (WST) in Q1 2026, closing a stake of 827 shares — an estimated $228K sold.
Nomura Holdings first reported a position in WST in Q1 2014 and held it in 32 quarters. The position peaked at $2.21M in Q3 2021. 753 funds tracked by Wall St. Rank hold WST as of Q1 2026.
- Nomura Holdings reported no remaining West Pharmaceutical position as of Q1 2026 after selling out during the quarter.
- Nomura Holdings sold 827 West Pharmaceutical shares in Q1 2026, an estimated $228K.
- Nomura Holdings first reported a position in West Pharmaceutical in Q1 2014 and held it in 32 quarters.
- Nomura Holdings's West Pharmaceutical position peaked at $2.21M in Q3 2021.
- 753 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.
Based on Nomura Holdings's 13F filing for Q1 2026, filed 15 May 2026.